Our hosting provider will be performing UPS maintenance on Tuesday, Oct 25, 2016 between 8 AM and 5 PM PDT. SciCrunch searching services will be down during this time.

Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Gene knockout of glycine transporter 1: characterization of the behavioral phenotype.


N-methyl-d-aspartate receptor (NMDAR) activation requires both the binding of glutamate to its recognition site and occupancy of the strychnine insensitive glycine modulatory site (GMS). Pharmacological studies suggest that the glycine transporter, GlyT1, maintains subsaturating concentrations of glycine at synaptic NMDARs. To characterize further the role of GlyT1, we generated mice in which the gene encoding GlyT1 was inactivated by homologous recombination through insertion of a PGK-Neo cassette in place of exons 2 and 3. Real-time quantitative PCR revealed no transcripts in newborn homozygous [GlyT1(-/-)] mice and a 50% reduction in heterozygous (HZ) [GlyT1(+/-)] mice as compared with WT littermates. The activity of Na(+)-dependent glycine transport in forebrain homogenates was similarly affected. Homozygous mice died within 12 h of birth. In acute hippocampal slices, exogenous glycine or d-serine (10 microM) enhanced NMDAR currents with Schaffer collateral stimulation in WT mice but not HZ mice, suggesting that the GMS was more occupied in the latter. The NMDAR/alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor ratio of the excitatory postsynaptic currents was significantly increased in the HZ mice. In the water maze, the HZ mice exhibited better spatial retention. Furthermore, HZ mice were less sensitive to an amphetamine disruption of prepulse inhibition than WT mice but were more sensitive to the effects of MK-801. Thus, reduced expression of GlyT1 enhances hippocampal NMDAR function and memory retention and protects against an amphetamine disruption of sensory gating, suggesting that drugs which inhibit GlyT1 might have both cognitive enhancing and antipsychotic effects.

Pubmed ID: 15159536


  • Tsai G
  • Ralph-Williams RJ
  • Martina M
  • Bergeron R
  • Berger-Sweeney J
  • Dunham KS
  • Jiang Z
  • Caine SB
  • Coyle JT


Proceedings of the National Academy of Sciences of the United States of America

Publication Data

June 1, 2004

Associated Grants

  • Agency: NIDA NIH HHS, Id: DA07252
  • Agency: NIDA NIH HHS, Id: DA12142
  • Agency: NIMH NIH HHS, Id: MH51290
  • Agency: NIMH NIH HHS, Id: P050MH60450
  • Agency: NINDS NIH HHS, Id: R44NS3459

Mesh Terms

  • Amino Acid Transport Systems, Neutral
  • Amphetamines
  • Animals
  • Behavior, Animal
  • Central Nervous System Stimulants
  • Dizocilpine Maleate
  • Excitatory Amino Acid Antagonists
  • Gene Targeting
  • Glycine
  • Glycine Plasma Membrane Transport Proteins
  • Hippocampus
  • In Vitro Techniques
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Motor Activity
  • Patch-Clamp Techniques
  • Phenotype
  • Prosencephalon
  • Receptors, N-Methyl-D-Aspartate
  • Serine
  • Sodium
  • Synapses